These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24206140)

  • 1. Development of RGD-based radiotracers for tumor imaging and therapy: translating from bench to bedside.
    Liu Z; Wang F
    Curr Mol Med; 2013 Dec; 13(10):1487-505. PubMed ID: 24206140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
    Liu S
    Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A concise review of current radiopharmaceuticals in tumor angiogenesis imaging.
    Lu X; Wang RF
    Curr Pharm Des; 2012; 18(8):1032-40. PubMed ID: 22272823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers.
    Tateishi U; Oka T; Inoue T
    Curr Med Chem; 2012; 19(20):3301-9. PubMed ID: 22664242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents.
    Ebenhan T; Kleynhans J; Zeevaart JR; Jeong JM; Sathekge M
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1414-1433. PubMed ID: 32918574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of Integrin α
    Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
    Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3.
    Chen H; Niu G; Wu H; Chen X
    Theranostics; 2016; 6(1):78-92. PubMed ID: 26722375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
    Chakravarty R; Chakraborty S; Dash A
    Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.
    Liu S
    Bioconjug Chem; 2015 Aug; 26(8):1413-38. PubMed ID: 26193072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
    Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview of Radiolabeled RGD Peptides for Theranostic Applications.
    Badipa F; Alirezapour B; Yousefnia H
    Curr Radiopharm; 2023; 16(2):107-122. PubMed ID: 36503458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.
    Chen X; Liu S; Hou Y; Tohme M; Park R; Bading JR; Conti PS
    Mol Imaging Biol; 2004; 6(5):350-9. PubMed ID: 15380745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET-Based Human Dosimetry of the Dimeric αvβ3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
    López-Rodríguez V; Galindo-Sarco C; García-Pérez FO; Ferro-Flores G; Arrieta O; Ávila-Rodríguez MA
    J Nucl Med; 2016 Mar; 57(3):404-9. PubMed ID: 26585063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).
    Zannetti A; Del Vecchio S; Iommelli F; Del Gatto A; De Luca S; Zaccaro L; Papaccioli A; Sommella J; Panico M; Speranza A; Grieco P; Novellino E; Saviano M; Pedone C; Salvatore M
    Clin Cancer Res; 2009 Aug; 15(16):5224-33. PubMed ID: 19671851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging.
    Yu HM; Chen JH; Lin KL; Lin WJ
    J Labelled Comp Radiopharm; 2015 Jun; 58(7):299-303. PubMed ID: 25997858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Galibert M; Boturyn D; Coll JL; Fukumura T; Saga T; Dumy P; Fujibayashi Y
    Nucl Med Biol; 2011 May; 38(4):529-40. PubMed ID: 21531290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of α
    Grönman M; Tarkia M; Kiviniemi T; Halonen P; Kuivanen A; Savunen T; Tolvanen T; Teuho J; Käkelä M; Metsälä O; Pietilä M; Saukko P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    J Transl Med; 2017 Jun; 15(1):144. PubMed ID: 28629432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.